The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety, tolerability and efficacy of 212Pb-DOTAMTATE as a targeted alpha therapy for subjects with unresectable or metastatic somatostatin receptor-expressing gastroenteropancreatic neuroendocrine tumors (SSTR+ GEP-NETs): A phase 2 study.
 
Jonathan R. Strosberg
Consulting or Advisory Role - Novartis
Research Funding - Alphamedix (Inst); ITM Solucin (Inst); Novartis (Inst); RayzeBio (Inst)
 
Shagufta Naqvi
No Relationships to Disclose
 
Allen Lee Cohn
No Relationships to Disclose
 
Ebrahim S Delpassand
Employment - Excel Diagnostics; RadioMedix
Leadership - Excel Diagnostics; RadioMedix
Stock and Other Ownership Interests - Excel Diagnostics; RadioMedix
Patents, Royalties, Other Intellectual Property - Curium Pharma; Fusion Pharmaceuticals; Radiomedix
 
Volker Jean Wagner
Employment - Bayer; Orano Med SAS
Leadership - Orano Med SAS
Stock and Other Ownership Interests - Amgen
 
Izabela Tworowska
Employment - Radiomedix
Stock and Other Ownership Interests - RadioMedix
 
Julien Torgue
Employment - AstraZeneca (I); Orano Med LLC
Leadership - Orano Med LLC
Stock and Other Ownership Interests - AstraZeneca (I); Bicycle Therapeutics; Molecular Partners
 
Rachel Woloski
Employment - Arcus Biosciences; Orano Med LLC
Stock and Other Ownership Interests - Arcus Biosciences
 
Allison Manuel
Employment - Astellas Pharma; Orano Med LLC
Stock and Other Ownership Interests - Lilly
 
Mary Alice Maluccio
No Relationships to Disclose